Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging
Clinical management in neuro-oncology has changed to an integrative approach that incorporates molecular profiles alongside histopathology and imaging findings. While the World Health Organization (WHO) guideline recommends the genotyping of informative alterations as a routine clinical practice for...
Main Authors: | Nastaran Khalili, Hossein Shooli, Nastaran Hosseini, Anahita Fathi Kazerooni, Ariana Familiar, Sina Bagheri, Hannah Anderson, Stephen J. Bagley, Ali Nabavizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/21/5198 |
Similar Items
-
Glioma Biopsy Based on Hybrid Dual Time-Point FET-PET/MRI—A Proof of Concept Study
by: Jacek Furtak, et al.
Published: (2021-05-01) -
Magnetic resonance imaging-guided prostate biopsy—A review of literature
by: Kulthe Ramesh Seetharam Bhat, et al.
Published: (2021-01-01) -
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy
by: Antonella Ninivaggi, et al.
Published: (2023-09-01) -
The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison
by: Gernot Ortner, et al.
Published: (2024-02-01) -
Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study
by: Michael Chaloupka, et al.
Published: (2023-02-01)